CIK 0002019410
- Non-accelerated filer
- Emerging growth company
Caris Life Sciences, Inc.
Sign in to watch- Ticker
- CAI
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- Operating
- EIN
- 852077369
- Phone
- +1 866-771-8946
- Business address
- 750 W JOHN CARPENTER FREEWAY, SUITE 800, IRVING, TX, 75039
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $27,204,813
- in 3 filings
Net −$27,204,813. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-15 | HALBERT DAVID D See Remarks | Shares withheld for taxes | −40,712 | $15.25 | $621K | 2,574,533 |
| 2026-03-06 | HALBERT DAVID D See Remarks | Grant or award | +320,112 | 2,615,245 | ||
| 2025-08-11 | HALBERT DAVID D See Remarks | Shares withheld for taxes | −141,956 | $29.75 | $4.2M | 2,295,133 |
| 2025-06-20 | HALBERT DAVID D See Remarks | Conversion | +104,761,535 | 121,025,002 | ||
| 2025-06-20 | HALBERT DAVID D See Remarks | Conversion · Series A Preferred Stock | −389,416,484 | 0 | ||
| 2025-06-20 | HALBERT DAVID D See Remarks | Conversion · Series B Preferred Stock | −29,629,630 | 0 | ||
| 2025-06-18 | HALBERT DAVID D See Remarks | Grant or award | +413,839 | 2,437,089 | ||
| 2025-03-25 | HALBERT DAVID D See Remarks | Grant or award | +360,750 | 2,023,250 |
Page 1 of 1 · 8 trades